Early hydroxyurea use is neuroprotective in children with sickle cell anemia
Kristine Karkoska, Amanda Pfeiffer, Dean W. Beebe, Charles T. Quinn, Omar Niss, Patrick T. McGann
Abstract
Children with sickle cell disease (SCD) who began hydroyxurea before age five years scored no differently on a measure of cognitive funciton than age, sex, and race-matched unaffected peers.
Topics & Concepts
MedicineSickle cell anemiaNeuroprotectionAnemiaPediatricsInternal medicineDiseaseHemoglobinopathies and Related DisordersBlood groups and transfusionIron Metabolism and Disorders